-
1
-
-
67649437765
-
Introduction and overview of the classification of the lymphoid neoplasms
-
Swerdlow S, et al., editors. Lyon: International Agency For Research On Cancer
-
Jaffe ES, Harris NL, Stein H, Campo E, Pileri SA, Swerdlow SH. Introduction and overview of the classification of the lymphoid neoplasms. In: Swerdlow S, et al., editors. WHO classification of tumors of hematopoietic and lymphoid tissues. Lyon: International Agency For Research On Cancer; 2008. p. 158-66.
-
(2008)
WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues
, pp. 158-166
-
-
Jaffe, E.S.1
Harris, N.L.2
Stein, H.3
Campo, E.4
Pileri, S.A.5
Swerdlow, S.H.6
-
2
-
-
84867176445
-
New molecular insight into peripheral T cell lymphomas
-
Pileri SA, Piccaluga PP. New molecular insight into peripheral T cell lymphomas. J Clin Invest. 2012;122:3448-55.
-
(2012)
J Clin Invest
, vol.122
, pp. 3448-3455
-
-
Pileri, S.A.1
Piccaluga, P.P.2
-
3
-
-
56049100260
-
Peripheral T cell lymphoma, not otherwise specified: The stuff of genes, dreams and therapies
-
Agostinelli C, Piccaluga PP, Went P, Rossi M, Gazzola A, Righi S, et al. Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies. J Clin Pathol. 2008;61:1160-7.
-
(2008)
J Clin Pathol
, vol.61
, pp. 1160-1167
-
-
Agostinelli, C.1
Piccaluga, P.P.2
Went, P.3
Rossi, M.4
Gazzola, A.5
Righi, S.6
-
4
-
-
51649091675
-
International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/ T-cell lymphoma study: Pathology findings and clinical outcomes
-
Vose J, Armitage J, Weisenburger D. International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/ T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124-30.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4124-4130
-
-
Vose, J.1
Armitage, J.2
Weisenburger, D.3
-
5
-
-
47049084821
-
International Peripheral T-Cell Lymphoma Project. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK? ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-cell Lymphoma Project
-
Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM, Rimsza L, Pileri SA, et al. International Peripheral T-Cell Lymphoma Project. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK? ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-cell Lymphoma Project. Blood. 2008;111:5496-504.
-
(2008)
Blood
, vol.111
, pp. 5496-5504
-
-
Savage, K.J.1
Harris, N.L.2
Vose, J.M.3
Ullrich, F.4
Jaffe, E.S.5
Connors, J.M.6
Rimsza, L.7
Pileri, S.A.8
-
6
-
-
84887253698
-
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: Results of a phase III diagnostic accuracy study
-
Piccaluga PP, Fuligni F, De Leo A, Bertuzzi C, Rossi M, Bacci F, et al. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study. J Clin Oncol. 2013;31:3019-25.
-
(2013)
J Clin Oncol
, vol.31
, pp. 3019-3025
-
-
Piccaluga, P.P.1
Fuligni, F.2
De Leo, A.3
Bertuzzi, C.4
Rossi, M.5
Bacci, F.6
-
7
-
-
36348982897
-
Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation
-
DOI 10.1158/0008-5472.CAN-07-1708
-
Piccaluga PP, Agostinelli C, Califano A, Carbone A, Fantoni L, Ferrari S, et al. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res. 2007;67:10703-10. (Pubitemid 350145896)
-
(2007)
Cancer Research
, vol.67
, Issue.22
, pp. 10703-10710
-
-
Piccaluga, P.P.1
Agostinelli, C.2
Califano, A.3
Carbone, A.4
Fantoni, L.5
Ferrari, S.6
Gazzola, A.7
Gloghini, A.8
Righi, S.9
Rossi, M.10
Tagliafico, E.11
Zinzani, P.L.12
Zupo, S.13
Baccarani, M.14
Pileri, S.A.15
-
8
-
-
77951906200
-
Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms
-
Piva R, Agnelli L, Pellegrino E, Todoerti K, Grosso V, Tamagno I, et al. Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol. 2010;28:1583-90.
-
(2010)
J Clin Oncol
, vol.28
, pp. 1583-1590
-
-
Piva, R.1
Agnelli, L.2
Pellegrino, E.3
Todoerti, K.4
Grosso, V.5
Tamagno, I.6
-
9
-
-
77649206608
-
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. International Peripheral T-Cell Lymphoma Project
-
Iqbal J, Weisenburger DD, Greiner TC, Vose JM, McKeithan T, Kucuk C, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. International Peripheral T-Cell Lymphoma Project. Blood. 2010;115:1026-36.
-
(2010)
Blood
, vol.115
, pp. 1026-1036
-
-
Iqbal, J.1
Weisenburger, D.D.2
Greiner, T.C.3
Vose, J.M.4
McKeithan, T.5
Kucuk, C.6
-
10
-
-
84880977905
-
CD30 expression in peripheral T-cell lymphomas
-
Sabattini E, Pizzi M, Tabanelli V, Baldin P, Sacchetti CS, Agostinelli C, et al. CD30 expression in peripheral T-cell lymphomas. Haematologica. 2013;98:e81-2.
-
(2013)
Haematologica
, vol.98
-
-
Sabattini, E.1
Pizzi, M.2
Tabanelli, V.3
Baldin, P.4
Sacchetti, C.S.5
Agostinelli, C.6
-
11
-
-
84880223497
-
Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: Alternative drivers in anaplastic large cell lymphoma
-
European T-cell Lymphoma Study Group
-
Tabbò F, Ponzoni M, Rabadan R, Bertoni F, Inghirami G, European T-cell Lymphoma Study Group. Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: alternative drivers in anaplastic large cell lymphoma. Curr Opin Hematol. 2013;20:374-81.
-
(2013)
Curr Opin Hematol
, vol.20
, pp. 374-381
-
-
Tabbò, F.1
Ponzoni, M.2
Rabadan, R.3
Bertoni, F.4
Inghirami, G.5
-
12
-
-
84865197558
-
Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters
-
Lemonnier F, Couronné L, Parrens M, Jaïs JP, Travert M, Lamant L, et al. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood. 2012;120:1466-9.
-
(2012)
Blood
, vol.120
, pp. 1466-1469
-
-
Lemonnier, F.1
Couronné, L.2
Parrens, M.3
Jaïs, J.P.4
Travert, M.5
Lamant, L.6
-
13
-
-
84857575341
-
IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma
-
Cairns RA, Iqbal J, Lemonnier F, Kucuk C, de Leval L, Jais JP, et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood. 2012;119:1901-3.
-
(2012)
Blood
, vol.119
, pp. 1901-1903
-
-
Cairns, R.A.1
Iqbal, J.2
Lemonnier, F.3
Kucuk, C.4
De Leval, L.5
Jais, J.P.6
-
14
-
-
84898660489
-
A targeted mutational landscape of angioimmunoblastic T cell lymphoma
-
Epub ahead of print
-
Odejide O, Weigert O, Lane AA, Toscano D, Lunning MA, Kopp N. A targeted mutational landscape of angioimmunoblastic T cell lymphoma. Blood. 2013 (Epub ahead of print).
-
(2013)
Blood
-
-
Odejide, O.1
Weigert, O.2
Lane, A.A.3
Toscano, D.4
Lunning, M.A.5
Kopp, N.6
-
15
-
-
85018246739
-
55th ASH annual meeting and exposition
-
Schatz JH, et al. 55th ASH annual meeting and exposition. Blood. 2013;122:843.
-
(2013)
Blood
, vol.122
, pp. 843
-
-
Schatz, J.H.1
-
16
-
-
84867256150
-
Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA
-
Delfau-Larue MH, de Leval L, Joly B, Plonquet A, Challine D, Parrens M, Delmer A. Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA. Haematologica. 2012;97:1594-602.
-
(2012)
Haematologica
, vol.97
, pp. 1594-1602
-
-
Delfau-Larue, M.H.1
De Leval, L.2
Joly, B.3
Plonquet, A.4
Challine, D.5
Parrens, M.6
Delmer, A.7
-
17
-
-
0028198206
-
Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma
-
Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's Lymphoma. Science. 1994;263:1281-4. (Pubitemid 24107549)
-
(1994)
Science
, vol.263
, Issue.5151
, pp. 1281-1284
-
-
Morris, S.W.1
Kirstein, M.N.2
Valentine, M.B.3
Dittmer, K.G.4
Shapiro, D.N.5
Saltman, D.L.6
Look, A.T.7
-
18
-
-
79960146011
-
Anaplastic large-cell lymphoma
-
European T-Cell Lymphoma Study Group. Review
-
Inghirami G, Pileri SA, European T-Cell Lymphoma Study Group. Anaplastic large-cell lymphoma. Semin Diagn Pathol. 2011;28:190-201 (Review).
-
(2011)
Semin Diagn Pathol
, vol.28
, pp. 190-201
-
-
Inghirami, G.1
Pileri, S.A.2
-
19
-
-
79961088497
-
Anaplastic-lymphoma kinase in human cancer
-
European T-Cell Lymphoma Study Group
-
Barreca A, Lasorsa E, Riera L, Machiorlatti R, Piva R, Ponzoni M, European T-Cell Lymphoma Study Group, et al. Anaplastic-lymphoma kinase in human cancer. J Mol Endocrinol. 2011;47:R11-23.
-
(2011)
J Mol Endocrinol
, vol.47
-
-
Barreca, A.1
Lasorsa, E.2
Riera, L.3
Machiorlatti, R.4
Piva, R.5
Ponzoni, M.6
-
20
-
-
61349130113
-
Anaplastic large cell lymphoma (ALCL), ALK-positive
-
Swerdlow S et al., editors. Lyon, France: International Agency For Research On Cancer
-
Delsol G, Jaffe ES, Falini B, Gascoyne RD, Muller-Hermelink HK, Stein H, Campo, et al. Anaplastic large cell lymphoma (ALCL), ALK-positive. In: Swerdlow S et al., editors. WHO classification of tumors of hematopoietic and lymphoid tissues. Lyon, France: International Agency For Research On Cancer; 2008. p. 312-16.
-
(2008)
WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues
, pp. 312-316
-
-
Delsol, G.1
Jaffe, E.S.2
Falini, B.3
Gascoyne, R.D.4
Muller-Hermelink, H.K.5
Stein, H.6
Campo7
-
21
-
-
20944435271
-
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
-
DOI 10.1038/nm1249
-
Chiarle R, Simmons WJ, Cai H, Dhall G, Zamo A, Raz R, et al. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat Med. 2005;11:623-9. (Pubitemid 40868302)
-
(2005)
Nature Medicine
, vol.11
, Issue.6
, pp. 623-629
-
-
Chiarle, R.1
Simmons, W.J.2
Cai, H.3
Dhall, G.4
Zamo, A.5
Raz, R.6
Karras, J.G.7
Levy, D.E.8
Inghirami, G.9
-
22
-
-
37549057005
-
The anaplastic lymphoma kinase in the pathogenesis of cancer
-
Review
-
Chiarle R, Voena C, Ambrogio C, Piva R, Inghirami G. The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat Rev Cancer. 2008; 8:11-23 (Review).
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 11-23
-
-
Chiarle, R.1
Voena, C.2
Ambrogio, C.3
Piva, R.4
Inghirami, G.5
-
23
-
-
85047699293
-
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
-
DOI 10.1038/sj/onc/1205152
-
Zamo' A, Chiarle R, Piva R, Howes J, Fan Y, Chilosi M, et al. Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene. 2002; 21:1038-47. (Pubitemid 34174516)
-
(2002)
Oncogene
, vol.21
, Issue.7
, pp. 1038-1047
-
-
Zamo, A.1
Chiarle, R.2
Piva, R.3
Howes, J.4
Fan, Y.5
Chilosi, M.6
Levy, D.E.7
Inghirami, G.8
-
24
-
-
44949166624
-
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination
-
DOI 10.1038/nm1769, PII NM1769
-
Chiarle R, Martinengo C, Mastini C, Ambrogio C, D'Escamard V, Forni G, et al. The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination. Nat Med. 2008;14: 676-80. (Pubitemid 351809545)
-
(2008)
Nature Medicine
, vol.14
, Issue.6
, pp. 676-680
-
-
Chiarle, R.1
Martinengo, C.2
Mastini, C.3
Ambrogio, C.4
D'Escamard, V.5
Forni, G.6
Inghirami, G.7
-
25
-
-
30444446194
-
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas
-
DOI 10.1182/blood-2005-05-2125
-
Piva R, Chiarle R, Manazza AD, Taulli R, Simmons W, Ambrogio C, et al. Ablation of oncogenic Alk is a viable therapeutic approach for anaplastic large-cell lymphomas. Blood. 2006;107:689-97. (Pubitemid 43076395)
-
(2006)
Blood
, vol.107
, Issue.2
, pp. 689-697
-
-
Piva, R.1
Chiarle, R.2
Manazza, A.D.3
Taulli, R.4
Simmons, W.5
Ambrogio, C.6
D'Escamard, V.7
Pellegrino, E.8
Ponzetto, C.9
Palestro, G.10
Inghirami, G.11
-
26
-
-
84876966952
-
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: A Children's Oncology Group phase 1 consortium study
-
Mossé YP, Lim MS, Voss SD, Wilner K, Ruffner K, Laliberte J, et al. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. Lancet Oncol. 2013;14:472-80.
-
(2013)
Lancet Oncol
, vol.14
, pp. 472-480
-
-
Mossé, Y.P.1
Lim, M.S.2
Voss, S.D.3
Wilner, K.4
Ruffner, K.5
Laliberte, J.6
-
28
-
-
0035252939
-
CIP1/WAF1 in the anaplastic large cell lymphoma cell line Karpas 299
-
DOI 10.1038/sj.onc.1204128
-
Hubinger G, Muller E, Scheffrahn I, et al. CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/ WAF1) in the anaplastic large cell lymphoma cell line Karpas 299. Oncogene. 2001;20:590-8. (Pubitemid 32156183)
-
(2001)
Oncogene
, vol.20
, Issue.5
, pp. 590-598
-
-
Hubinger, G.1
Muller, E.2
Scheffrahn, I.3
Schneider, C.4
Hildt, E.5
Singer, B.B.6
Sigg, I.7
Graf, J.8
Bergmann, L.9
-
29
-
-
39549084701
-
CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells
-
DOI 10.2353/ajpath.2008.070858
-
Hirsch B, Hummel M, Bentink S, et al. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells. Am J Pathol. 2008;172:510-20. (Pubitemid 351282036)
-
(2008)
American Journal of Pathology
, vol.172
, Issue.2
, pp. 510-520
-
-
Hirsch, B.1
Hummel, M.2
Bentink, S.3
Fouladi, F.4
Spang, R.5
Zollinger, R.6
Stein, H.7
Durkop, H.8
-
30
-
-
34447573999
-
Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma
-
DOI 10.1200/JCO.2006.07.8972
-
Ansell SM, Horwitz SM, Engert A, Khan KD, Lin T, Strair R, Keler T, et al. Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma. J Clin Oncol. 2007;25:2764-9. (Pubitemid 47123185)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.19
, pp. 2764-2769
-
-
Ansell, S.M.1
Horwitz, S.M.2
Engert, A.3
Khan, K.D.4
Lin, T.5
Strair, R.6
Keler, T.7
Graziano, R.8
Blanset, D.9
Yellin, M.10
Fischkoff, S.11
Assad, A.12
Borchmann, P.13
-
31
-
-
23944469381
-
The fully human anti-CD30 antibody 5F11 activates NF-kappaB and sensitizes lymphoma cells to bortezomib-induced apoptosis
-
DOI 10.1182/blood-2005-01-0427
-
Boll B, Hansen H, Heuck F, et al. The fully human anti-CD30 antibody 5F11 activates NF-{kappa}B and sensitizes lymphoma cells to bortezomib-induced apoptosis. Blood. 2005;106:1839-42. (Pubitemid 41208602)
-
(2005)
Blood
, vol.106
, Issue.5
, pp. 1839-1842
-
-
Boll, B.1
Hansen, H.2
Heuck, F.3
Reiners, K.4
Borchmann, P.5
Rothe, A.6
Engert, A.7
Von Strandmann, E.P.8
-
32
-
-
0028837618
-
In vivo antitumor effects of unconjugated CD30 monoclonal antibodies on human anaplastic large-cell lymphoma xenografts
-
Tian ZG, Longo DL, Funakoshi S, et al. In vivo antitumor effects of unconjugated CD30 monoclonal antibodies on human anaplastic large-cell lymphoma xenografts. Cancer Res. 1995;55: 5335-41.
-
(1995)
Cancer Res
, vol.55
, pp. 5335-5341
-
-
Tian, Z.G.1
Longo, D.L.2
Funakoshi, S.3
-
33
-
-
67649908324
-
A phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma
-
Forero-Torres A, Leonard JP, Younes A, Rosenblatt JD, Brice P, Bartlett NL, et al. A phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma. Br J Haematol. 2009;146:171-9.
-
(2009)
Br J Haematol
, vol.146
, pp. 171-179
-
-
Forero-Torres, A.1
Leonard, J.P.2
Younes, A.3
Rosenblatt, J.D.4
Brice, P.5
Bartlett, N.L.6
-
34
-
-
78049515807
-
Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas
-
Younes A, Bartlett NL, Leonard JP, Kennedy DA, Lynch CM, Sievers EL, et al. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. N Engl J Med. 2011;363:1812-21.
-
(2011)
N Engl J Med
, vol.363
, pp. 1812-1821
-
-
Younes, A.1
Bartlett, N.L.2
Leonard, J.P.3
Kennedy, D.A.4
Lynch, C.M.5
Sievers, E.L.6
-
35
-
-
65349133281
-
Anaplastic large cell lymphoma (ALCL), ALK-negative
-
Swerdlow S, et al., editors. Lyon: International Agency For Research On Cancer
-
Mason DY, Harris NL, Delsol G, Stein H, Campo E, Kinney MC, et al. Anaplastic large cell lymphoma (ALCL), ALK-negative. In: Swerdlow S, et al., editors. WHO classification of tumors of hematopoietic and lymphoid tissues. Lyon: International Agency For Research On Cancer; 2008. p. 317-9.
-
(2008)
WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues
, pp. 317-319
-
-
Mason, D.Y.1
Harris, N.L.2
Delsol, G.3
Stein, H.4
Campo, E.5
Kinney, M.C.6
-
36
-
-
78751692894
-
Discovery of recurrent t(6;7) (p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing
-
Feldman AL, Dogan A, Smith DI, Law ME, Ansell SM, Johnson SH, et al. Discovery of recurrent t(6;7) (p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood. 2011;117:915-9.
-
(2011)
Blood
, vol.117
, pp. 915-919
-
-
Feldman, A.L.1
Dogan, A.2
Smith, D.I.3
Law, M.E.4
Ansell, S.M.5
Johnson, S.H.6
-
37
-
-
84869221316
-
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas
-
Laimer D, Dolznig H, Kollmann K, Vesely PW, Schlederer M, Merkel O, et al. PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. Nat Med. 2012;18:1699-704.
-
(2012)
Nat Med
, vol.18
, pp. 1699-1704
-
-
Laimer, D.1
Dolznig, H.2
Kollmann, K.3
Vesely, P.W.4
Schlederer, M.5
Merkel, O.6
-
38
-
-
0016237489
-
Angio-immunoblastic lymphadenopathy with dysproteinemia
-
Frizzera G, Moran E, Rappaport H. Angio-immunoblastic lymphadenopathy with dysproteinemia. Lancet. 1974;1:1070-3.
-
(1974)
Lancet
, vol.1
, pp. 1070-1073
-
-
Frizzera, G.1
Moran, E.2
Rappaport, H.3
-
39
-
-
65349158859
-
Angioimmunoblastic T-cell lymphoma
-
Swerdlow S, et al., editors. Lyon: International Agency For Research On Cancer
-
Dogan A, Gaulard P, Jaffe E, Ralfkiaer E, Muller-Hermelink H, et al. Angioimmunoblastic T-cell lymphoma. In: Swerdlow S, et al., editors. WHO classification of tumors of hematopoietic and lymphoid tissues. Lyon: International Agency For Research On Cancer; 2008. p. 309-31.
-
(2008)
WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues
, pp. 309-331
-
-
Dogan, A.1
Gaulard, P.2
Jaffe, E.3
Ralfkiaer, E.4
Muller-Hermelink, H.5
-
40
-
-
0027300193
-
B-cell lymphoma after angioimmunoblastic lymphadenopathy: A case with oligoclonal gene rearrangements associated with Epstein-Barr virus
-
Abruzzo LV, Schmidt K, Weiss LM, et al. B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus. Blood. 1993;82:241-6. (Pubitemid 23188770)
-
(1993)
Blood
, vol.82
, Issue.1
, pp. 241-246
-
-
Abruzzo, L.V.1
Schmidt, K.2
Weiss, L.M.3
Jaffe, E.S.4
Medeiros, L.J.5
Sander, C.A.6
Raffeld, M.7
-
41
-
-
0032052104
-
Development of Epstein-Barr virus-associated B cell lymphoma after intensive treatment of patients with angioimmunoblastic lymphadenopathy with dysproteinemia
-
PII S092557109800005X
-
Matsue K, Itoh M, Tsukuda K, Kokubo T, Hirose Y. Development of Epstein-Barr virus-associated B cell lymphoma after intensive treatment of patients with angioimmunoblastic lymphadenopathy with dysproteinemia. Int J Hematol. 1998;67: 319-29. (Pubitemid 28257145)
-
(1998)
International Journal of Hematology
, vol.67
, Issue.3
, pp. 319-329
-
-
Matsue, K.1
Itoh, M.2
Tsukuda, K.3
Kokubo, T.4
Hirose, Y.5
-
42
-
-
0036798752
-
Angio-immunoblastic T cell lympboma (AILD-TL) rich in large B cells and associated with Epstein-Barr virus infection. A different subytpe of AILD-TL?
-
DOI 10.1038/sj.leu.2402642
-
Lome-Maldonado C, Canioni D, Hermine O, et al. Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein-Barr virus infection: a different subtype of AILD-TL? Leukemia. 2002;16:2134-41. (Pubitemid 35203459)
-
(2002)
Leukemia
, vol.16
, Issue.10
, pp. 2134-2141
-
-
Lome-Maldonado, C.1
Canioni, D.2
Hermine, O.3
Delabesse, E.4
Damotte, D.5
Raffoux, E.6
Gaulard, P.7
Macintyre, E.8
Brousse, N.9
-
43
-
-
33746877544
-
Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma
-
DOI 10.1097/01.pas.0000209855.28282.ce, PII 0000047820060700000003
-
Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ. Programmed death-1 (PD-1) is a marker of germinal center associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2006;30:802-10. (Pubitemid 44264969)
-
(2006)
American Journal of Surgical Pathology
, vol.30
, Issue.7
, pp. 802-810
-
-
Dorfman, D.M.1
Brown, J.A.2
Shahsafaei, A.3
Freeman, G.J.4
-
44
-
-
33744992010
-
Marker expression in peripheral T-cell lymphoma: A proposed clinical-pathologic prognostic score
-
DOI 10.1200/JCO.2005.03.6327
-
Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E, et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol. 2006;24:2472-9. (Pubitemid 46630624)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.16
, pp. 2472-2479
-
-
Went, P.1
Agostinelli, C.2
Gallamini, A.3
Piccaluga, P.P.4
Ascani, S.5
Sabattini, E.6
Bacci, F.7
Falini, B.8
Motta, T.9
Paulli, M.10
Artusi, T.11
Piccioli, M.12
Zinzani, P.L.13
Pileri, S.A.14
-
45
-
-
33746651491
-
Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with activated follicular B helper T cells [6]
-
DOI 10.1182/blood-2006-01-0394
-
Krenacs L, Schaerli P, Kis G, Bagdi E. Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with activated follicular B helper T cells. Blood. 2006;108:1110-1. (Pubitemid 44154657)
-
(2006)
Blood
, vol.108
, Issue.3
, pp. 1110-1111
-
-
Krenacs, L.1
Schaerli, P.2
Kis, G.3
Bagdi, E.4
-
46
-
-
35748959075
-
Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma
-
DOI 10.3324/haematol.10864
-
Roncador G, Garcia Verdes-Montenegro JF, Tedoldi S, Paterson JC, Klapper W, Ballabio E, et al. Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica. 2007;92:1059-66. (Pubitemid 350144212)
-
(2007)
Haematologica
, vol.92
, Issue.8
, pp. 1059-1066
-
-
Roncador, G.1
Verdes-Montenegro, J.-F.G.2
Tedoldi, S.3
Paterson, J.C.4
Klapper, W.5
Ballabio, E.6
Maestre, L.7
Pileri, S.8
Hansmann, M.-L.9
Piris, M.A.10
Mason, D.Y.11
Marafioti, T.12
-
47
-
-
34249652415
-
FH) cells
-
DOI 10.1182/blood-2006-10-055145
-
de Leval L, Rickman DS, Thielen C, Reynies Ad, Huang YL, Delsol G, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T cells (TFH). Blood. 2007;109:4952-63. (Pubitemid 46827794)
-
(2007)
Blood
, vol.109
, Issue.11
, pp. 4952-4963
-
-
De Leval, L.1
Rickman, D.S.2
Thielen, C.3
De Reynies, A.4
Huang, Y.-L.5
Delsol, G.6
Lamant, L.7
Leroy, K.8
Briere, J.9
Molina, T.10
Berger, F.11
Gisselbrecht, C.12
Xerri, L.13
Gaulard, P.14
-
48
-
-
69349093225
-
Interleukin-17 and type 17 helper T cells
-
Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009;361:888-98.
-
(2009)
N Engl J Med
, vol.361
, pp. 888-898
-
-
Miossec, P.1
Korn, T.2
Kuchroo, V.K.3
-
49
-
-
77957286394
-
Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma
-
Tripodo C, Gri G, Piccaluga PP, Frossi B, Guarnotta C, Piconese S, Franco G, et al. Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma. Am J Pathol. 2010;177: 792-802.
-
(2010)
Am J Pathol
, vol.177
, pp. 792-802
-
-
Tripodo, C.1
Gri, G.2
Piccaluga, P.P.3
Frossi, B.4
Guarnotta, C.5
Piconese, S.6
Franco, G.7
-
50
-
-
8344254359
-
Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression
-
DOI 10.1038/labinvest.3700145
-
Zhao WL, Mourah S, Mounier N, Leboeuf C, Daneshpouy ME, Legrès L, et al. Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression. Lab Invest. 2004;84:1512-9. (Pubitemid 39482168)
-
(2004)
Laboratory Investigation
, vol.84
, Issue.11
, pp. 1512-1519
-
-
Zhao, W.-L.1
Mourah, S.2
Mounier, N.3
Leboeuf, C.4
Daneshpouy, M.E.5
Legres, L.6
Meignin, V.7
Oksenhendler, E.8
Le, M.C.9
Calvo, F.10
Briere, J.11
Gisselbrecht, C.12
Janin, A.13
-
51
-
-
27644555656
-
Complete remission in a patient with relapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumab [4]
-
DOI 10.1038/sj.leu.2403936, PII 2403936
-
Bruns I, Fox F, Reinecke P, Kobbe G, Kronenwett R, Jung G, Haas R. Complete remission in a patient withrelapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumab. Leukemia. 2005;19:1993-5. (Pubitemid 41554011)
-
(2005)
Leukemia
, vol.19
, Issue.11
, pp. 1993-1995
-
-
Bruns, I.1
Fox, F.2
Reinecke, P.3
Kobbe, G.4
Kronenwett, R.5
Jung, G.6
Haas, R.7
-
52
-
-
0036121580
-
Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: Two case reports
-
DOI 10.1080/10428190210190
-
Strupp C, Aivado M, Germing U, Gattermann N, Haas R. Angioimmunoblastic lymphadenopathy (AILD) mayrespond to thalidomide treatment: two case reports. Leuk Lymphoma. 2002;43:133-7. (Pubitemid 34223981)
-
(2002)
Leukemia and Lymphoma
, vol.43
, Issue.1
, pp. 133-137
-
-
Strupp, C.1
Aivado, M.2
Germing, U.3
Gattermann, N.4
Haas, R.5
-
53
-
-
18644372042
-
Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide [3]
-
DOI 10.1038/sj.leu.2403710
-
Dogan A, Ngu LS, Ng SH, Cervi PL. Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide. Leukemia. 2005;19:873-5. (Pubitemid 40663113)
-
(2005)
Leukemia
, vol.19
, Issue.5
, pp. 873-875
-
-
Dogan, A.1
Ngu, L.S.P.2
Ng, S.H.3
Cervi, P.L.4
-
54
-
-
70349636649
-
Activity of lenalidamide in a phase II trial for T-cell lymphoma: Report on the first 24 cases
-
abstr 8524
-
Dueck GS, Chua N, Prasad A, Stewart D, White D, van der Jagt R, et al. Activity of lenalidamide in a phase II trial for T-cell lymphoma: report on the first 24 cases. J Clin Oncol. 2009; 27:439s (suppl; abstr 8524).
-
(2009)
J Clin Oncol
, vol.27
, Issue.SUPPL.
-
-
Dueck, G.S.1
Chua, N.2
Prasad, A.3
Stewart, D.4
White, D.5
Van Der Jagt, R.6
-
55
-
-
84899427557
-
55th ASH annual meeting and exposition
-
Sakata-Yanagimoto M, et al. 55th ASH annual meeting and exposition. Blood. 2013;122:815.
-
(2013)
Blood
, vol.122
, pp. 815
-
-
Sakata-Yanagimoto, M.1
-
56
-
-
84899434696
-
55th ASH annual meeting and exposition
-
Palomero T, et al. 55th ASH annual meeting and exposition. Blood. 2013;122:846.
-
(2013)
Blood
, vol.122
, pp. 846
-
-
Palomero, T.1
-
57
-
-
74049098626
-
High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus
-
Hartmann S, Gesk S, Scholtysik R, Kreuz M, Bug S, Vater I, et al. High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus. Br J Haematol. 2010;148:402-12.
-
(2010)
Br J Haematol
, vol.148
, pp. 402-412
-
-
Hartmann, S.1
Gesk, S.2
Scholtysik, R.3
Kreuz, M.4
Bug, S.5
Vater, I.6
-
58
-
-
42449134368
-
Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma
-
DOI 10.1111/j.1365-2141.2008.07042.x
-
Nelson M, Horsman DE, Weisenburger DD, Gascoyne RD, Dave BJ, Loberiza FR. Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma. Br J Haematol. 2008;141:461-9. (Pubitemid 351565676)
-
(2008)
British Journal of Haematology
, vol.141
, Issue.4
, pp. 461-469
-
-
Nelson, M.1
Horsman, D.E.2
Weisenburger, D.D.3
Gascoyne, R.D.4
Dave, B.J.5
Loberiza, F.R.6
Ludkovski, O.7
Savage, K.J.8
Armitage, J.O.9
Sanger, W.G.10
-
59
-
-
58949084192
-
Array comparative genomic hybridization analysis of PTCL-U reveals a distinct subgroup with genetic alterations similar to lymphoma-type adult T-cell leukemia/ lymphoma
-
Nakagawa M, Nakagawa-Oshiro A, Karnan S, Tagawa H, Utsunomiya A, Nakamura S. Array comparative genomic hybridization analysis of PTCL-U reveals a distinct subgroup with genetic alterations similar to lymphoma-type adult T-cell leukemia/ lymphoma. Clin Cancer Res. 2009;15:30-8.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 30-38
-
-
Nakagawa, M.1
Nakagawa-Oshiro, A.2
Karnan, S.3
Tagawa, H.4
Utsunomiya, A.5
Nakamura, S.6
-
60
-
-
33749241701
-
Peripheral T-cell lymphoma gene expression profiles
-
DOI 10.1002/hon.781
-
Martinez-Delgado B. Peripheral T-cell lymphoma gene expression profiles. Hematol Oncol. 2006;24:113-9. (Pubitemid 44483903)
-
(2006)
Hematological Oncology
, vol.24
, Issue.3
, pp. 113-119
-
-
Martinez-Delgado, B.1
-
61
-
-
28544433590
-
Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas
-
DOI 10.1038/sj.leu.2403960, PII 2403960
-
Martinez-Delgado B, Cuadros M, Honrado E, Ruiz de la Parte A, Roncador G, Alves J, et al. Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas. Leukemia. 2005;19:2254-63. (Pubitemid 41741622)
-
(2005)
Leukemia
, vol.19
, Issue.12
, pp. 2254-2263
-
-
Martinez-Delgado, B.1
Cuadros, M.2
Honrado, E.3
De La, P.A.R.4
Roncador, G.5
Alves, J.6
Castrillo, J.M.7
Rivas, C.8
Benitez, J.9
Martinez-Delgado, B.10
Ferreira, J.A.11
Menargues, J.12
Mollejo, M.13
Bellas, C.14
Campo, E.15
Saez, A.16
Jimenez, F.17
Nieto, S.18
Acevedo, A.19
Rodriguez, P.J.L.20
Garcia, C.M.21
Montalban, C.22
Briones, J.23
Espinosa, I.24
Alvaro, T.25
Dominguez, P.26
Gonzales, C.J.27
Firteza, J.28
Contra, T.29
more..
-
62
-
-
33644834348
-
Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas
-
DOI 10.1038/sj.onc.1209178, PII 1209178
-
Ballester B, Ramuz O, Gisselbrecht C, Doucet G, Loi L, Loriod B, et al. Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene. 2006;25: 1560-70. (Pubitemid 43361941)
-
(2006)
Oncogene
, vol.25
, Issue.10
, pp. 1560-1570
-
-
Ballester, B.1
Ramuz, O.2
Gisselbrecht, C.3
Doucet, G.4
Loi, L.5
Loriod, B.6
Bertucci, F.7
Bouabdallah, R.8
Devilard, E.9
Carbuccia, N.10
Mozziconacci, M.-J.11
Birnbaum, D.12
Brousset, P.13
Berger, F.14
Salles, G.15
Briere, J.16
Houlgatte, R.17
Gaulard, P.18
Xerri, L.19
-
63
-
-
34548254943
-
Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas
-
DOI 10.1200/JCO.2006.09.4474
-
Cuadros M, Dave SS, Jaffe ES, Honrado E, Milne R, Alves J, et al. Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. J Clin Oncol. 2007;25: 3321-9. (Pubitemid 47325619)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.22
, pp. 3321-3329
-
-
Cuadros, M.1
Dave, S.S.2
Jaffe, E.S.3
Honrado, E.4
Milne, R.5
Alves, J.6
Rodriguez, J.7
Zajac, M.8
Benitez, J.9
Staudt, L.M.10
Martinez-Delgado, B.11
-
64
-
-
31444450512
-
Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma
-
DOI 10.1038/sj.leu.2404045, PII 2404045
-
Streubel B, Vinatzer U, Willheim M, Chott A. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia. 2006;20:313-8. (Pubitemid 43148670)
-
(2006)
Leukemia
, vol.20
, Issue.2
, pp. 313-318
-
-
Streubel, B.1
Vinatzer, U.2
Willheim, M.3
Raderer, M.4
Chott, A.5
-
65
-
-
65449136285
-
Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas
-
Huang Y, Moreau A, Dupuis J, Streubel B, Petit B, Le Gouill S, et al. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol. 2009;33:682-90.
-
(2009)
Am J Surg Pathol
, vol.33
, pp. 682-690
-
-
Huang, Y.1
Moreau, A.2
Dupuis, J.3
Streubel, B.4
Petit, B.5
Le Gouill, S.6
-
66
-
-
84876149606
-
Inimitable Imatinib: The range of targeted tumours expands to include T-cell lymphoma
-
Turner SD. Inimitable Imatinib: the range of targeted tumours expands to include T-cell lymphoma. Leukemia. 2013;27:759.
-
(2013)
Leukemia
, vol.27
, pp. 759
-
-
Turner, S.D.1
-
67
-
-
84857522968
-
Final results from a pivotal, multicenter, international open-label, phase 2 study of Romidepsin in progressive or relapsed peripheral T-cell lymphoma (PTCL) following prior systemic therapy
-
Coiffier B, Pro B, Prince M, et al. Final results from a pivotal, multicenter, international open-label, phase 2 study of Romidepsin in progressive or relapsed peripheral T-cell lymphoma (PTCL) following prior systemic therapy. J Clin Oncol. 2012;30:631-6.
-
(2012)
J Clin Oncol
, vol.30
, pp. 631-636
-
-
Coiffier, B.1
Pro, B.2
Prince, M.3
-
68
-
-
30344470789
-
Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures
-
DOI 10.1158/1535-7163.MCT-05-0146
-
Mahadevan D, Spier C, Della Croce K, Miller S, George B, Riley C, et al. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures. Mol Cancer Ther. 2005;4: 1867-79. (Pubitemid 43056970)
-
(2005)
Molecular Cancer Therapeutics
, vol.4
, Issue.12
, pp. 1867-1879
-
-
Mahadevan, D.1
Spier, C.2
Della, C.K.3
Miller, S.4
George, B.5
Riley, C.6
Warner, S.7
Grogan, T.M.8
Miller, T.P.9
-
69
-
-
79751531010
-
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gamma/delta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro
-
Iqbal J, Weisenburger DD, Chowdhury A, Tsai MY, Srivastava G, Greiner TC, et al. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gamma/delta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro. Leukemia. 2011;25: 348-58.
-
(2011)
Leukemia
, vol.25
, pp. 348-358
-
-
Iqbal, J.1
Weisenburger, D.D.2
Chowdhury, A.3
Tsai, M.Y.4
Srivastava, G.5
Greiner, T.C.6
-
70
-
-
84875373630
-
Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endoreduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment
-
Qia W, Spiera C, Liua X, Agarwala A, Cookea LS, Perskyb DO, et al. Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endoreduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment. Leuk Res. 2013;37:434-9.
-
(2013)
Leuk Res
, vol.37
, pp. 434-439
-
-
Qia, W.1
Spiera, C.2
Liua, X.3
Agarwala, A.4
Cookea, L.S.5
Perskyb, D.O.6
-
71
-
-
84904540138
-
Phase II study of Alisertib, a selective Aurora-Kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas
-
Epub ahead of print
-
Friedberg JW, Mahadevan D, Cebula E, Persky D, Lossos I, Agarwal AB, et al. Phase II study of Alisertib, a selective Aurora-Kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas. J Clin Oncol. 2013 (Epub ahead of print).
-
(2013)
J Clin Oncol
-
-
Friedberg, J.W.1
Mahadevan, D.2
Cebula, E.3
Persky, D.4
Lossos, I.5
Agarwal, A.B.6
-
72
-
-
84899465678
-
55th ASH annual meeting and exposition
-
Ferrando AA, et al. 55th ASH annual meeting and exposition. Blood. 2013;122:811.
-
(2013)
Blood
, vol.122
, pp. 811
-
-
Ferrando, A.A.1
-
73
-
-
79961060207
-
Peripheral T-cell lymphoma classification: The matter of cellular derivation
-
Piccaluga PP, Agostinelli C, Tripodo C, Gazzola A, Bacci F, Sabattini E, Pileri SA. Peripheral T-cell lymphoma classification: the matter of cellular derivation. Expert Rev Hematol. 2011;4(4):415-25.
-
(2011)
Expert Rev Hematol
, vol.4
, Issue.4
, pp. 415-425
-
-
Piccaluga, P.P.1
Agostinelli, C.2
Tripodo, C.3
Gazzola, A.4
Bacci, F.5
Sabattini, E.6
Pileri, S.A.7
|